We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Integra Lifesciences Holdings Corp (IART) USD0.01

Sell:$17.00 Buy:$17.03 Change: $0.05 (0.30%)
NASDAQ:1.22%
Market closed |  Prices as at close on 4 October 2024 | Switch to live prices |
Sell:$17.00
Buy:$17.03
Change: $0.05 (0.30%)
Market closed |  Prices as at close on 4 October 2024 | Switch to live prices |
Sell:$17.00
Buy:$17.03
Change: $0.05 (0.30%)
Market closed |  Prices as at close on 4 October 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Integra LifeSciences Holdings Corporation is a global medical technology company. The Company manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS business consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield, Bactiseal, and Certas Plus, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. The Company provides instruments that are used in precision, specialty and general surgical procedures. The TT segment is focused on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair. The TT segment offers skin and wound repair, bone grafts, and nerve and tendon repair products.

Contact details

Address:
1100 Campus Road
PRINCETON
08540
United States
Telephone:
+1 (609) 2750500
Website:
https://www.integralife.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
IART
ISIN:
US4579852082
Market cap:
$1.34 billion
Shares in issue:
77.58 million
Sector:
Health Care Equipment
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Stuart Essig
    Executive Chairman of the Board
  • Jan De Witte
    President, Chief Executive Officer, Director
  • Lea Knight
    Chief Financial Officer, Executive Vice President
  • Chantal Veillon
    Chief Human Resource Officer, Executive Vice President
  • Eric Schwartz
    Executive Vice President, Chief Legal Officer, Secretary
  • Robert Davis
    Executive Vice President, President - Tissue Technologies
  • Michael Mcbreen
    Executive Vice President and President - Codman Specialty Surgical
  • Harvinder Singh
    Executive Vice President, President - International Business
  • Jeffrey Mosebrook
    Senior Vice President - Finance, Principal Accounting Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.